Introduction to CJC-1295 in Research
CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) developed for controlled laboratory investigations. It was designed by modifying the native GHRH(1–29) peptide sequence, incorporating a drug affinity complex moiety that allows reversible binding to serum albumin. This structural adaptation prolongs the presence of the peptide in circulation within experimental models, offering researchers a stable tool to study pulsatile growth hormone secretion over extended periods. Investigators in endocrinology and metabolic research employ CJC-1295 to examine the GHRH receptor signaling cascade, downstream effects on insulin-like growth factor-1 (IGF-1) levels, and the interplay between the somatotropic axis and metabolic homeostasis. All descriptions of CJC-1295 provided here refer exclusively to its application in scientific studies. The product is strictly for laboratory research use and is not intended for human or veterinary purposes.
What Is CJC-1295?
CJC-1295 is a 30‑amino acid peptide chain based on the first 29 residues of endogenous GHRH, with an additional cysteine residue at the C‑terminus. This cysteine enables conjugation to a maleimide‑functionalized reactive group that selectively binds cysteine‑34 of serum albumin. Once bound, the peptide‑albumin complex resists rapid proteolytic degradation and renal clearance, yielding a functional half‑life measured in days rather than minutes in animal models. In research systems, CJC-1295 acts as a GHRH receptor agonist, binding to the pituitary somatotroph GHRH receptor and stimulating adenylate cyclase activity, which leads to increased synthesis and secretion of growth hormone. Experimental protocols frequently use CJC-1295 in cell‑based assays, tissue explants, and animal models to dissect the regulatory mechanisms of the growth hormone/IGF‑1 axis, evaluate receptor desensitization patterns, and explore the relationship between growth hormone pulses and metabolic parameters. Owing to its extended action profile, it is a valuable tool for studies requiring sustained receptor activation without the need for continuous infusion.
Importance of Certificate of Analysis (COA) for Research Peptides
A Certificate of Analysis (COA) is a foundational document that accompanies every batch of a research peptide, providing objective, third‑party‑verified data on the product’s identity, purity, and physicochemical properties. For investigations where reproducibility is critical, the COA serves as a quality benchmark, confirming that the peptide meets predefined specifications. The document typically reports the net peptide content, enabling accurate molar calculations when preparing stock solutions. It also includes results from orthogonal analytical techniques, most commonly reversed‑phase high‑performance liquid chromatography (HPLC) and electrospray ionization mass spectrometry (MS). HPLC quantifies the relative purity, usually expressed as percent area under the curve at a specific wavelength, while MS confirms the exact molecular mass within accepted tolerance limits. Additional parameters, such as solubility observations, residual counter‑ion content (e.g., trifluoroacetate), and water content determined by Karl Fischer titration, may be present depending on the supplier’s quality panel. Without a COA, researchers risk working with degraded or misidentified material, which can compromise data integrity, waste resources, and undermine the validity of peer‑reviewed publications. For laboratories operating under good laboratory practice (GLP) or preparing material for pre‑clinical study reports, a detailed COA is an essential part of the traceability chain.
Selecting a CJC-1295 Supplier with COA
When sourcing CJC‑1295 for laboratory experiments, the presence and quality of the COA should be a primary selection criterion. A reputable CJC-1295 supplier with COA will transparently share batch‑specific analytical data before or at the time of shipment, allowing the end user to assess suitability for the intended study. Institutions may wish to evaluate the supplier’s approach to quality management by examining the scope of testing, the instrumentation used, and whether the COA is generated by an independent analytical unit rather than solely by the synthesis team. The documentation should clearly state the catalog number, lot or batch number, date of analysis, and storage recommendations. Researchers are encouraged to contact the supplier’s technical support team with questions about peak integration methods, column specifications, or MS ionization modes; a technically adept supplier will respond with precise detail.
Quality Assurance Standards
A robust quality assurance program for CJC‑1295 begins with solid‑phase peptide synthesis using Fmoc chemistry, followed by rigorous purification steps, typically preparative HPLC, to isolate the target molecule from truncated sequences and deletion by‑products. The final lyophilized peptide should be characterized by analytical HPLC demonstrating a purity level of ≥98%, with the chromatogram showing a single predominant peak. Mass spectrometry data should confirm the monoisotopic mass within ±1 Da of the theoretical value (for CJC‑1295 with an albumin‑binding conjugate, the expected mass depends on the exact linker chemistry; a fully conjugated form has a distinct mass that should be explicitly reported). Additional tests may include peptide content analysis via amino acid analysis or UV spectrophotometry, counter‑ion quantification, and endotoxin determination if required for cell culture work. Suppliers adhering to these standards often perform stability‑indicating studies under recommended storage conditions and can provide data on reconstitution behavior. Such thorough characterization supports consistent batch‑to‑batch performance and is especially critical for longitudinal studies where multiple batches may be used across time points.
文件记录与透明度
A complete COA for CJC‑1295 should go beyond purity and mass identity. It should include the percent purity by HPLC and the retention time, the molecular ion peaks observed by MS (with the calculated and observed masses), and the overall net peptide content, which directly affects the preparation of accurate concentration series. Information on storage—such as recommended temperature, protection from light, and anticipated stability after reconstitution in sterile buffers—is an indicator of the supplier’s familiarity with the peptide’s handling characteristics. Transparency in documentation also means traceability: the COA typically references the synthesis workflow, purification steps, and the analytical laboratory that performed the release testing. Suppliers willing to disclose the column chemistry and gradient conditions used during HPLC analysis allow researchers to replicate purity checks in their own laboratories if desired. Such openness reduces the risk of receiving counterfeit or mislabeled material and supports the integrity of research data. When evaluating a CJC-1295 supplier with COA, note whether the document is signed and dated by a quality assurance officer and whether it clearly links to the product’s physical label. This level of detail reflects a commitment to scientific rigor and builds confidence among academic and industrial buyers alike.
How to Verify COA Authenticity
Verifying the authenticity of a COA is a straightforward process that protects the quality of research. Begin by checking that the lot number on the COA matches the lot number printed on the peptide vial label and any accompanying packaging. Examine the documentation for official letterhead, date of issue, and a signature or electronic approval from the quality department. The analytical data should be internally consistent; for example, the mass spectrum should show peaks corresponding to the expected molecular ion, and the HPLC chromatogram should integrate to the stated purity percentage without unexplained shoulders or fronting. Researchers can cross‑reference the reported molecular weight with published values for the specific CJC‑1295 variant they ordered. If any discrepancy arises, contacting the supplier is the next step. A reliable supplier will be able to explain the analytical conditions, provide raw data files upon request, or arrange re‑testing if there is reasonable doubt. In collaborative multi‑site studies, it is prudent to share COAs among laboratories so that all participants work with verified material, thereby enhancing the robustness of comparative data.
Why Choose Our CJC-1295 with COA
Our organization focuses on the synthesis and supply of research‑grade peptides, including CJC‑1295, under tightly controlled manufacturing conditions that meet the demands of academic laboratories, pharmaceutical research teams, and global distributors. Every batch of CJC‑1295 is produced using optimized solid‑phase protocols, purified to high homogeneity, and lyophilized in an inert atmosphere to preserve molecular integrity. Before release, each batch undergoes independent analytical evaluation at a partner laboratory that employs calibrated HPLC systems and high‑resolution mass spectrometers. The resulting COA is a comprehensive document that reports purity (routinely exceeding 98%), mass identity confirmation, and net peptide content. We understand that timelines in research can be critical; therefore, we maintain sufficient stock levels and offer reliable worldwide shipping with appropriate cold‑chain packaging when needed. Our technical staff includes peptide chemists and analytical specialists who can discuss method validation, stability data, and handling recommendations. By choosing our CJC‑1295 with COA, research institutions gain access to a well‑characterized reagent that supports reproducible experimental outcomes and simplifies compliance with internal quality guidelines.
Ordering Information for Research Institutions and Distributors
CJC‑1295 is available in multiple pack sizes, ranging from milligram quantities suitable for pilot studies to gram‑scale batches for large‑scale screening programs. Bulk orders and custom synthesis requests are accommodated through a dedicated project management team that can tailor synthesis scales, packaging formats, and analytical deliverables to specific project needs. All shipments include the Certificate of Analysis, a safety data sheet, and documentation required for customs clearance. Distributors benefit from direct access to batch‑level data, consistent packaging with tamper‑evident seals, and support for re‑labeling where local regulations require it. To request a quotation, discuss a custom synthesis, or inquire about our quality systems, please contact our sales team through the official channels listed on our website.
仅限研究用途： All products described are intended solely for in vitro laboratory experimentation and scientific research. They are not for use in humans or animals in a diagnostic, therapeutic, or clinical context. Purchasers must be qualified professionals acting within an appropriate institutional framework, and they bear responsibility for ensuring compliance with all applicable laws and regulations governing the procurement and use of research chemicals.
仅限研究用途。不得用于人类或兽医用途。.
